The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLD.L Regulatory News (RLD)

  • There is currently no data for RLD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Equity Fundraising of £150,000

13 Jan 2020 07:00

RNS Number : 5146Z
Richland Resources Ltd
13 January 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION.

This announcement does not constitute a prospectus or offering memorandum or an offer in respect of any securities and is not intended to provide the basis for any investment decision in respect of Richland Resources Ltd or other evaluation of any securities of Richland Resources Ltd or any other entity and should not be considered as a recommendation that any investor should subscribe for or purchase any such securities.

13 January 2020

Richland Resources Ltd

("Richland" or the "Company")

 Equity Fundraising of approximately £150,000 gross

 

Richland (AIM: RLD) is pleased to announce that the Company has conditionally raised, in aggregate, approximately £150,000 (before expenses) through a placing of 105,000,000 new common shares of US$0.0003 each in the capital of the Company ("Common Shares") (the "Placing Shares") (the "Placing") with certain new investors at an issue price of 0.10 pence per Placing Share (the "Issue Price") and a subscription for a further 45,000,000 new Common Shares (the "Subscription Shares") by a new investor also at the Issue Price (the "Subscription") (the Placing and Subscription together being the "Equity Fundraising").

 

Details of the Equity Fundraising

The Placing was arranged via Peterhouse Capital Limited ("Peterhouse") as agent of the Company. Pursuant to the Placing and Subscription, in aggregate, 150,000,000 new Common Shares will be issued at the Issue Price to certain new investors. The Issue Price represents a discount of approximately 5 per cent. to the closing price of a Common Share of 0.105 pence on 9 January 2020, which was used to set the Issue Price, and a discount of approximately 31 per cent. to the closing middle market price of a Common Share of 0.145 pence on 10 January 2020, being the latest practicable business day prior to this announcement.

 

Peterhouse are due 5 per cent. commission on the gross proceeds of the Placing and 1 per cent. commission on the gross proceeds of the Subscription which it has agreed will be settled by the issue of 5,700,000 new Common Shares to Peterhouse (the "Commission Shares"). In addition, Peterhouse has agreed that its initial six monthly retainer fee for 2020 will be settled by the issue to it of a further 10,000,000 new Common Shares at the Issue Price (the "Broker Fee Shares").

 

The Equity Fundraising is conditional upon admission of the Placing Shares and Subscription Shares to trading on AIM ("Admission").

 

The Placing Shares and Subscription Shares (together, the "Equity Fundraising Shares") represent, in aggregate, approximately 14.64 per cent. of the Company's enlarged issued share capital (as enlarged by the Equity Fundraising Shares, the Commission Shares and the Broker Fee Shares). The Equity Fundraising Shares, Commission Shares and Broker Fee Shares will rank pari passu in all respects with the Company's existing Common Shares and will be issued fully paid.

 

Admission to trading

Application will be made to the London Stock Exchange for Admission of the abovementioned new Common Shares and it is expected that Admission will become effective and that dealings in the Equity Fundraising Shares, Commission Shares and Broker Fee Shares (together, the "New Shares") will commence at 8.00 a.m. on 16 January 2020. Following Admission, the Company will have 1,024,839,558 Common Shares with voting rights in issue and holds a further 7,275,000 Common Shares in treasury.

Use of Proceeds

As previously announced on 2 January 2020, the Company is currently an AIM Rule 15 cash shell and, as such, is required to complete a reverse takeover under AIM Rule 14 or otherwise seek re-admission to trading on AIM as an investing company pursuant to AIM Rule 8 by 30 June 2020. Accordingly, the Company is seeking to identify a suitable reverse takeover transaction in the mining sector and the net proceeds from the Equity Fundraising will be utilised to provide the Company with additional general working capital and to satisfy the costs and expenses associated with pursuing such a transaction. However, there can be no guarantee that the Company will be able to secure a suitable reverse takeover transaction and subsequently be re-admitted to AIM.

 

 

For further information, please contact:

 

Anthony Brooke

Chief Executive Officer

+66 81 854 1755

 

Edward Nealon

Chairman

+61 409 969 955

 

Mike Allardice

Group Company Secretary

+852 91 864 854

 

Nominated Adviser

Strand Hanson Limited

James Harris

Matthew Chandler

James Bellman

+44 (0) 20 7409 3494

 

Broker

Peterhouse Capital Limited

Duncan Vasey / Lucy Williams (Broking)

Eran Zucker (Corporate Finance)

+44 (0) 20 7469 0930

 

 

 

 

 

 

     

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014.

 

Note to Editors:

Further information is available on the Company's website: www.richlandresourcesltd.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEGPUUGGUPUGRP
Date   Source Headline
7th Dec 20203:00 pmRNSChange of Name and Grant of Options
3rd Dec 20201:54 pmRNSHolding(s) in Company
23rd Nov 20204:45 pmRNSResult of AGM and Total Voting Rights
10th Nov 20208:00 amRNSSchedule One - Richland Resources Ltd
2nd Nov 20207:00 amRNSUpdate re Proposed Reverse Takeover Transaction
29th Sep 20203:30 pmRNSInterim Results for half-year ended 30 June 2020
27th Jul 20207:00 amRNSProposed Reverse Takeover Transaction
1st Jul 20207:30 amRNSSuspension of Trading on AIM & Corporate Update
1st Jul 20207:30 amRNSSuspension - Richland Resources Ltd
23rd Apr 20202:05 pmRNSSecond Price Monitoring Extn
23rd Apr 20202:01 pmRNSPrice Monitoring Extension
23rd Apr 202010:15 amRNSHolding(s) in Company
7th Apr 202011:15 amRNSFinal Results
2nd Apr 20204:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
31st Mar 202010:00 amRNSHolding(s) in Company
20th Mar 20202:20 pmRNSHolding(s) in Company
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20203:30 pmRNSPlacing of approximately £100,000 gross
10th Mar 20204:12 pmRNSHolding(s) in Company
3rd Mar 202011:02 amRNSHolding(s) in Company
26th Feb 20202:47 pmRNSHolding(s) in Company
13th Jan 20207:00 amRNSEquity Fundraising of £150,000
2nd Jan 20207:00 amRNSCompletion of Disposal of Capricorn Sapphire
23rd Dec 20197:00 amRNSExtension and Amendment to Option Agreement
16th Dec 20197:00 amRNSExtension and Amendment to Option Agreement
9th Dec 20197:00 amRNSFurther Extension to Amended Option Agreement
18th Nov 20197:00 amRNSExtension to Amended Option Agreement
31st Oct 20199:04 amRNSExtension to Amended Option Agreement
30th Sep 20197:00 amRNSInterim Results for half-year ended 30 June 2019
29th Aug 20192:30 pmRNSFee Conversions and Director's Dealing
21st Aug 20199:01 amRNSHolding(s) in Company
19th Aug 20194:53 pmRNSHolding(s) in Company
19th Aug 20194:51 pmRNSHolding(s) in Company
19th Aug 20193:47 pmRNSResult of AGM and Update re: Option Agreement
29th Jul 20198:39 amRNSNotice of Annual General Meeting
22nd Jul 20197:00 amRNSAmendment to Option Agreement
18th Jul 201910:47 amRNSUpdate re: Option Agreement
9th Jul 20191:03 pmRNSHolding(s) in Company
9th Jul 201912:32 pmRNSHolding(s) in Company
9th Jul 201912:27 pmRNSHolding(s) in Company
4th Jul 20197:15 amRNSEquity Fundraising & Appointment of Broker
28th Jun 201911:30 amRNSFinal Results
3rd Jun 20197:00 amRNSExtension of Loan Facility and Strategy Update
1st May 20197:30 amRNSExtension of Loan Facility and Strategy Update
1st Apr 20197:00 amRNSExtension of Loan Facility and Strategy Update
28th Feb 201912:00 pmRNSExtension of Loan Facility and Strategy Update
2nd Jan 20197:00 amRNSStrategic update and Convertible Loan Facility
28th Sep 20184:20 pmRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.